Matthew R Henn

7PUBLICATIONS
51CO-AUTHORS
Medical infection agents (incl. prions)Epidemiological modellingMedical bacteriologyInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 06, 2026
The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome.

Jessica A Bryant, Marin Vulić, Emily A Walsh

|Oct 27, 2025
External Perfusion Centers Can Bridge the Gap of Experience During Ex Vivo Lung Perfusion: A United Network for Organ Sharing Database Study.

Martin G Walsh, Ervin Y Cui, Theodore Dimitrov

|Aug 02, 2025
Comparability of Gastrointestinal Microbiome and Bile Acid Profiles in Patients With First or Multiply Recurrent Clostridioides difficile Infection.

Jessica A Bryant, Timothy J Straub, Darrell S Pardi

|Apr 08, 2024
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity.

Isabella C Glitza, Yongwoo David Seo, Christine N Spencer

|Sep 23, 2022
SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent Clostridioides difficile Infection (rCDI).

Sahil Khanna, Matthew Sims, Thomas J Louie

|Feb 06, 2021
Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection.

Charmaine Normington, Ines B Moura, Jessica A Bryant

Pageof 2

Frequent Collaborators

3 joint publications

Jessica A Bryant

2 joint publications

Timothy J Straub

2 joint publications

Jennifer Wortman

2 joint publications

Christopher B Ford